ASX Announcement

Completion of Viral Vector Manufacturing for Phase 1 trial

Published: 09/03/23, 08:17am (AEST)3 pages
Chimeric Therapeutics Limited
CHM:ASXHealthcare

Recent CHM Announcements

Price Sensitive only